Benjamin HickeyFiled
- BMYBRISTOL MYERS SQUIBB COPresident, RayzeBio Org.filed Mar 12, 2026
Monthly open-market value · 24 months Filed
- Bought (open market)
- Sold (open market)
Unusual activity Estimated
- 50Insider overlapPublic Jan 13, 2026 · traded Apr 28, 2025
Rep. Julia Letlow sold BMY 11 days before its President sold $4K
Details
- Politician
- Julia Letlow
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company Common Stock (BMY)
- Tx type
- sell
- Traded
- Apr 28, 2025
- Filed
- Jan 13, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 260
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- -11
- Opposite side
- No
- Public from
- Jan 13, 2026
- Method version
- 2026-11-03
- 50Insider overlapPublic Jun 22, 2025 · traded May 12, 2025
Rep. Jefferson Shreve sold BMY 3 days after its President sold $4K
Details
- Politician
- Jefferson Shreve
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company Common Stock (BMY)
- Tx type
- sell
- Traded
- May 12, 2025
- Filed
- Jun 22, 2025
- Amount low
- $15,001
- Amount high
- $50,000
- Range midpoint (estimate)
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 41
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- 3
- Opposite side
- No
- Public from
- Jun 22, 2025
- Method version
- 2026-11-03
- 50Insider overlapPublic Jun 10, 2025 · traded May 19, 2025
Rep. Ro Khanna's dependent child partially sold BMY 10 days after its President sold $4K
Details
- Politician
- Ro Khanna
- Ticker
- BMY
- Asset
- BRISTOL-MYERS SQUIBB COMPANY Cmn
- Tx type
- partial_sale
- Traded
- May 19, 2025
- Filed
- Jun 10, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 22
- Owner type
- dependent
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- 10
- Opposite side
- No
- Public from
- Jun 10, 2025
- Method version
- 2026-11-03
- 50Insider overlapPublic May 15, 2025 · traded Apr 15, 2025
Sen. Tommy Tuberville sold BMY 24 days before its President sold $4K
Details
- Politician
- Tommy Tuberville
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company
- Tx type
- sell
- Traded
- Apr 15, 2025
- Filed
- May 15, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 30
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- -24
- Opposite side
- No
- Public from
- May 15, 2025
- Method version
- 2026-11-03
Transactions
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice. Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4; the whale score is a model ranking of that filed activity.